42nd Annual J.P. Morgan Healthcare Conference

Revolutionizing human health at an accelerated [rev] speed Embracing the impossible to improve lives [vita] | --- | --- | --- | --- | |----------------------------------------------------------------|------------------|---------------------------------------------------------|----------------------------------------| | | | 2023E Non-Covid Revenue Mix Life Sciences \n~47% ~$2.7B | Consumables, Services, Software ~80% | | Expanding the boundaries of human potential through science | ~53% Diagnostics | | Instr ...